Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
OPT Opthea
- 3.340
- +0.110+3.41%
Close Dec 20 16:00 ET
514.00MMarket Cap-1.21P/E (TTM)
3.530High3.230Low15.20KVolume3.230Open3.230Pre Close50.72KTurnover0.02%Turnover RatioLossP/E (Static)153.89MShares5.45052wk High-6.78P/B322.81MFloat Cap1.79052wk Low--Dividend TTM96.65MShs Float16.230Historical High--Div YieldTTM9.29%Amplitude1.600Historical Low3.337Avg Price1Lot Size
About Opthea Company
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.
Company Profile
SymbolOPT
Company NameOpthea
Issue Price13.50
Founded1984
CEODr. Frederic Guerard, Pharm.D.
MarketNASDAQ
Employees34
Securities TypeDR
ADS Ratio1.0 : 8.0
Fiscal Year Ends06-30
Address650 Chapel Street,Suite 0403,Level 4
CitySouth Yarra
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3141
Phone61-3-9826-0399
Websitehttp://www.opthea.com
Company Executives
- Name
- Position
- Salary
- Dr. Frederic Guerard, Pharm.D.
- Chief Executive Officer
- 1.32M
- Peter F. Lang
- Chief Financial Officer
- 1.16M
- Judith J. Robertson
- Chief Commercial Officer
- 715.10K
- Dr. Megan Baldwin
- Chief Innovation Officer and Executive Director
- 1.36M
- Fang Li, PhD
- Senior Vice President, Regulatory
- --
- Kevin Bitter
- Vice President, Strategy & Corporate Development
- --
- Dr. John Han
- Vice President, Medical Affairs
- --
- Karen Adams
- Vice President, Finance and Company Secretary
- 466.17K
- Mark O Neill
- Vice President, Chemistry, Manufacturing and Controls
- --
- Julie Clark
- Senior Vice President, Clinical Development
- --
- Bruno Gagnon
- Senior Vice President, Global Clinical Operations
- --
- Jeremy M. Levin, D.Phil.,M.B.
- Chairman of the Board
- 309.43K
- Anshul Thakral
- Director
- 103.72K
- Dr. Julia A. Haller, M.D.
- Director
- 170.25K
- Susan Orr
- Independent Director
- 130.26K
- Sujal Shah
- Independent Director
- 16.72K
- Quinton Oswald
- Independent Director
- 135.81K
- Lawrence B. Gozlan
- Independent Director
- 790.52K